Search clinical trials for: Fibrin hydrogel

Total 6699 results

Fundació Institut de Recerca de l'Hospital de la...

Terminated

Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study) (BERTA)

Long-term Oral Anticoagulant Therapy

Spain
ARCA Biopharma, Inc.

Completed

Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices

Catheters, Indwelling

United States
Ontario Clinical Oncology Group (OCOG)
Pfizer

Completed

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Ovarian Cancer

Canada
Sanofi

Completed

Enoxaparin in Acute Venous Thromboembolic Disease

Venous Thrombosis

Turkey
Assaf-Harofeh Medical Center

Completed

Pharmacological Study That Measures Omeprazole Effect on Aspirins Absorption in Healthy Volunteers

Aspirin Blood Level | Proton Pump Inhiditor Treatment

Israel
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Precancerous/Nonmalignant Condition

United States
Luzerner Kantonsspital
Pfizer

Completed

Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function

Renal Insufficiency

Switzerland
Aeris Therapeutics

Terminated

Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

Pulmonary Emphysema

Netherlands
Asan Medical Center
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Overcome Biochemical Aspirin Resistance Through Cilostazol Combination (ARCC)

Cerebral Infarction

Korea, Republic of
Aeris Therapeutics

Completed

Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

Chronic Obstructive Pulmonary Disease | Pulmonary Emphysema

Israel
Temple University

Completed

The Effect of Implementing Hyper-acute Stroke Guidelines on Decision-Making for or Against Thrombolytic Therapy for Stroke in the Emergency Department

Stroke

United States
Asan Medical Center
Korea Otsuka International Asia Arab

Completed

Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II (TOSS-2)

Atherosclerosis | Cerebral Infarction

Philippines, Korea, Republic of, Thailand, Hong Kong
Neurobiological Technologies

Terminated

ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Stroke | Brain Infarction | Cerebral Ischemia

United States, Australia, Israel, South Africa, Slovakia, New Zealand, Austria, Czech Republic, Poland, Russian Federation, Switzerland
University of North Carolina, Chapel Hill

Completed

Daily Vitamin K in Patients on Warfarin With Unstable INRs

Anticoagulants | Warfarin

United States
National Taiwan University Hospital

Unknown

Investigation of Platelet Function and Aspirin Resistance in Chronic Dialysis Patient

End Stage Renal Disease

Taiwan
Neurobiological Technologies

Terminated

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Stroke | Brain Infarction | Cerebral Ischemia

Taiwan, United States, Australia, South Africa, Canada, Czech Republic, Netherlands, Poland, Russian Federation, United Kingdom
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Bioavailability Study of Cilostazol Tablets, 50mg

Therapeutic Equivalency, Healthy
Mutual Pharmaceutical Company, Inc.

Completed

Fasted Bioavailability Study of Cilostazol Tablets, 100 mg

Therapeutic Equivalency
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Cilostazol for the Indication of CSPS

Cerebral Infarction

Korea, Republic of
University of North Carolina, Chapel Hill

Completed

Mechanisms Underlying Drug-Diet Interactions

Pharmacokinetics

United States
Korea Otsuka Pharmaceutical Co., Ltd.
Seoul National University Boramae Hospital; Korea Otsuka International Asia...

Completed

Cilostazol in Acute Ischemic Stroke Treatment (CAIST)

Cerebral Infarction

Korea, Republic of
Bayer

Completed

Symptomatic Treatment of Common Cold Symptoms

Common Cold

Italy
University Hospital, Saarland
Baxter Healthcare Corporation; Pharmacia GmbH, Erlangen, Germany

Completed

Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (TAHHT)

Hereditary Hemorrhagic Telangiectasia

Germany
Bayer

Completed

Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain

Low Back Pain

United Kingdom, Germany
Yodakubo Hospital

Completed

Effect of Tranexamic Acid on Reducing Postoperative Blood Loss in Cervical Laminoplasty

Cervical Myelopathy
National Taiwan University Hospital
Haemonetics Corporation

Unknown

Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay

30 Healthy People

Taiwan
Centre Hospitalier Universitaire Dijon

Completed

Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery

Retinal Detachment

France
Medical University of Vienna

Unknown

Heparin for Pregnant Women With Thrombophilia

Pregnancy and Thrombophilia

Austria
Free University Medical Center

Completed

Epoprostenol in Pulmonary Embolism

Acute Pulmonary Embolism

Netherlands
Royal Brompton & Harefield NHS Foundation Trust

Unknown

Early Percutaneous Coronary Intervention (PCI) After Fibrinolysis Versus Standard Therapy in ST Segment Elevation Myocardial Infarction (STEMI) Patients

Myocardial Infarction

United Kingdom
Eli Lilly and Company

Completed

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY) (IOOY)

Diabetes Mellitus Type 2

Korea, Republic of, Hungary, United States, Mexico, Argentina, India, Poland, Taiwan, Spain
Mayo Clinic

Completed

A Preliminary Study of a New Tranexamic Acid Dosing Schedule for Cardiac Surgery

Cardiac Surgery
Gyeongsang National University Hospital

Completed

Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism (ACCELAMI2C19)

Myocardial Infarction

Korea, Republic of
OMRIX Biopharmaceuticals

Completed

Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy (Fleece)

Nephrectomy | Hemostatic Techniques

Israel
Schering-Plough

Withdrawn

A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)

Myocardial Infarction | Coronary Disease

United States, France, Canada
Tel-Aviv Sourasky Medical Center

Unknown

Antiplatelet Therapy Continuation in Spine Surgery - Its Effect on Postoperative Morbidity and Mortality

Myocardial Infarction | Hemorrhage | Deep Vein Thrombosis | Cerebrovascular Accident | Pulmonary Embolism

Israel
Corbridge Group Philippines, Inc.
Alfasigma S.p.A.

Unknown

The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney Disease (DEFINE)

Chronic Kidney Disease

Philippines
Sanofi
Bristol-Myers Squibb

Terminated

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

Atrial Fibrillation | Vascular Risk

United States, France, Canada, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Denmark, Finland, H... and more
Pfizer

Terminated

Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients

Venous Thromboembolism

India
University of Pennsylvania
Bayer; National Institutes of Health (NIH)

Completed

Mechanism Based Resistance to Aspirin

Aspirin Resistance | Pharmacological Aspirin Non-responsiveness
Mayo Clinic
Medtronic

Completed

Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass (Heparin Dosing)

Postoperative Hemorrhage

United States
Sanofi

Completed

Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)

Acute Coronary Syndrome
Okayama University

Completed

Tranexamic Acid in Pediatric Cardiac Surgery (TXA)

Blood Loss | Congenital Heart Disease
Shenyang Northern Hospital

Completed

Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention

Ischemic Heart Disease | Acute Coronary Syndromes

China
Abbott

Completed

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

Dyslipidemia

United States
Sanofi

Completed

Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery

Hip Fractures

Japan
Tehran University of Medical Sciences
University of Birmingham

Completed

Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease (Polypill)

Hypertension | Cardiovascular Disease | Heart Disease | Hyperlipidemia

Iran, Islamic Republic of
Royal College of Surgeons, Ireland
Irish Heart Foundation

Completed

Enteric Coating as a Factor in Aspirin Resistance

Cardiovascular Disease

Ireland
Iladevi Cataract and IOL Research Center

Completed

Clinical Trial on Anti-inflammatory Effect of Low-Molecular Weight Heparin in Pediatric Cataract Surgery

Inflammation

India
GRACIA Group
Spanish Ministry of Health.; Spanish Ministry of Science and Innovation

Completed

Role of Tirofiban and the Paclitaxel Eluting Stent in Postfibrinolysis Angioplasty (GRACIA3)

Myocardial Infarction

Spain

Search clinical trials for: Fibrin hydrogel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations